Actionnariat et activité des initiés pour Bicycle Therapeutics plc (BCYC): transactions des initiés, déclarations de trading du Sénat et de la Chambre américaine et actions en circulation. Suivez comment dirigeants et politiciens négocient le titre.
Prix
| Prix | $3.64 |
| Capitalisation | $253M |
| Bourse | NASDAQ |
| Pays | GB |
Bilan (10 ans)
| Année | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Trésorerie | $9.4M | $67.7M | $63.4M | $92.1M | $136.0M | $438.7M | $339.2M | $526.4M | $879.5M | $628.1M |
| Placements à Court Terme | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Créances | $1.4M | $3.0M | $11.3M | $7.1M | $14.6M | $11.9M | $21.2M | $24.0M | $35.7M | $35.6M |
| Stocks | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Courants | $11.3M | $71.5M | $76.8M | $104.1M | $155.7M | $458.6M | $369.4M | $561.9M | $928.6M | $682.9M |
| Immobilisations Corporelles | $519000 | $1.4M | $1.8M | $4.3M | $3.6M | $17.8M | $32.8M | $27.7M | $17.2M | $21.9M |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Incorporels | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Totaux | $11.8M | $74.0M | $81.6M | $110.2M | $161.2M | $479.8M | $410.6M | $595.3M | $956.9M | $717.6M |
| Dettes Fournisseurs | $1.9M | $2.1M | $1.9M | $1.9M | $1.4M | $2.7M | $6.5M | $13.1M | $15.8M | $9.7M |
| Dette à Court Terme | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $4.9M | 0 | $2.8M |
| Passifs Courants | $3.8M | $9.5M | $8.9M | $8.8M | $23.1M | $36.2M | $53.3M | $69.5M | $67.2M | $57.0M |
| Dette à Long Terme | 0 | 0 | 0 | 0 | $14.5M | $29.9M | $30.3M | $30.7M | 0 | 0 |
| Passifs Totaux | $3.8M | $121.2M | $151.5M | $17.0M | $65.7M | $133.5M | $139.8M | $224.4M | $163.8M | $107.6M |
| Réserves | -$31.8M | -$48.1M | -$69.9M | -$100.5M | -$151.6M | -$218.4M | -$331.1M | -$511.8M | -$680.8M | -$899.8M |
| Capitaux Propres | $8.0M | -$47.2M | -$69.8M | $93.2M | $95.5M | $346.3M | $270.8M | $370.9M | $793.1M | $610.0M |
| Dette Totale | 0 | 0 | 0 | $1.9M | $15.8M | $44.3M | $44.3M | $45.0M | $9.5M | $17.5M |
| Dette Nette | -$9.4M | -$67.7M | -$63.4M | -$90.2M | -$120.2M | -$394.3M | -$294.8M | -$481.5M | -$870.0M | -$610.6M |
| Fonds de Roulement | $7.5M | $62.1M | $67.8M | $95.3M | $132.6M | $422.3M | $316.0M | $492.3M | $861.4M | $625.9M |
Santé financière
| Dette / Capitaux propres | 0.03 |
| Ratio de liquidité | 12.08 |
Rentabilité
| Rentabilité des capitaux propres | -33.22% |
| Rentabilité du capital investi | -37.63% |
| Rentabilité des actifs | -31.39% |
| Marge brute | 100.00% |
| Marge opérationnelle | -343.69% |
| Marge nette | -311.11% |
Entreprises liées: ADCT · CMPX · FDMT · FULC · KALV · LXRX · NMRA
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de BCYC: Vue d'ensemble · Financiers · Valorisation · Statistiques · Estimations · Technique · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions